Advertisement
Advertisement
U.S. Markets open in 1 hr 2 mins
Advertisement
Advertisement
Advertisement
Advertisement

RenovaCare, Inc. (RCAR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9700+0.0400 (+4.30%)
At close: 02:53PM EST
Advertisement

RenovaCare, Inc.

4 Becker Farm Road
Suite 105
Roseland, NJ 07068
United States
888 398 0202
http://www.renovacareinc.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees2

Key Executives

NameTitlePayExercisedYear Born
Dr. Robin A. Robinson Ph.D.Chairman of Scientific Advisory Board & Chief Scientific Officer344.97kN/A1956
Mr. Alan L. RubinoConsultant645.97kN/A1955
Dr. Kaiyo Nedd M.D.Pres, CEO & DirectorN/AN/A1974
Mr. Justin Frere CPA, M.B.A., MBA, CPACFO, Treasurer & Sec.N/AN/A1973
Dr. Jo Ellen Schweinle M.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Roseland, New Jersey.

Corporate Governance

RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement